Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject ...

Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis: Victoria, British Columbia Thursday, November 14, 2024, ...

Here are some facts about Vivek Ramaswamy, a Cincinnati native who has been tapped to oversee the newly formed Department of ...

A unique opera experience that explores voice loss and identity has been produced by scientists at the UCL Ear Institute in ...

Recently, an SLP who works exclusively in FEES (Fiberoptic Endoscopic Evaluation of Swallowing) voiced her frustration with ...

Let’s dissect seven multiple sclerosis symptoms that Black people should recognize, and what they can do to address them.

A Henderson woman was charged with neglect of a dependent causing death last week following an investigation into the death ...

President-elect Donald trump has announced that billionaire Elon Musk and Vivek Ramaswamy, a former presidential candidate ...

Top quality health care requires a team of skilled professionals working in collaboration with doctors and nurses ...

Overwhelming shareholder support in favour of take-private transaction with AditxtStudies presented at IDWeek 2024™ demonstrate ATI-1701 provides ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...